Refractory Medulloblastoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab1Recruiting1
DB12048Savolitinib1Recruiting1
DB04690Camptothecin1 / 2Active Not Recruiting1
DB00762Irinotecan1 / 2Active Not Recruiting1
DB11740MK-17751 / 2Active Not Recruiting1
DB00126Ascorbic acid2Recruiting1
DB00112Bevacizumab2Active Not Recruiting1
DB04690Camptothecin2Active Not Recruiting1
DB14860Ensartinib2Recruiting2
DB12147Erdafitinib2Recruiting1
DB14491Ferrous fumarate2Recruiting1
DB15127Hydrogen2Recruiting1
DB00762Irinotecan2Active Not Recruiting1
DB15763Iron polymaltose2Recruiting1
DB14568Ivosidenib2Recruiting1
DB12167LY-30234142Recruiting1
DB16541Lactobacillus casei2Recruiting1
DB14723Larotrectinib2Recruiting1
DB00825Levomenthol2Recruiting1
DB09074Olaparib2Recruiting2
DB09073Palbociclib2Recruiting2
DB15685Selpercatinib2Recruiting2
DB11689Selumetinib2Recruiting1
DB14546Sulfate ion2Recruiting1
DB12887Tazemetostat2Active Not Recruiting1
DB12887Tazemetostat2Recruiting1
DB00853Temozolomide2Active Not Recruiting1
DB04960Tipifarnib2Recruiting2
DB13930Ulixertinib2Recruiting1
DB13930Ulixertinib2Suspended1
DB08881Vemurafenib2Recruiting1
DB13104X-3962Recruiting2